Mandate

Vinge advises SBB in connection with its sale to Brookfield

Vinge advises Samhällsbyggnadsbolaget i Norden AB (publ) ("SBB") in connection with its sale of stake in its social infrastructure portfolio for public education to Brookfield for SEK 9.2 billion. The transaction also includes earn out payments up to SEK 1.2 billion.

SBB contributes its SEK 44.9 billion social infrastructure portfolio for public education to a newly formed SBB subsidiary EduCo AB (“EduCo”). Brookfield, one of the world’s largest infrastructure investors, through its open-ended core infrastructure fund (Brookfield Super-Core Infrastructure Partners), acquires a 49% minority stake in EduCo from SBB for approx. SEK 9.2 billion in cash up front, plus up to approx. SEK 1.2 billion in cash through earn-outs. EduCo will be operated and managed by SBB through an asset management agreement with respect to the management of the EduCo portfolio in its entirety.

Vinge’s team consisted of Jesper Schönbeck, Rikard Lindahl and Joel Wahlberg (Capital markets and Public M&A), Niclas Winnberg, Karolina Cohrs, Frida Ställborn, Kristoffer Larsson and Anette Kahn (Real Estate and Social Infrastructure), Albert Wållgren, Linn Adelwald and Axel Jansson (Financing), Maria Dahlin Kolvik and Sebastian Saadieh (M&A), Marcus Glader and Trine Osen Bergqvist (Competition and Regulatory) and Robert Wikholm (Restructuring and Insolvency).

 

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025